Tech Company Financing Transactions
Strata Oncology Funding Round
On 6/3/2016, Strata Oncology raised $12 million in Series A financing from Arboretum Ventures, Baird Capital and Michigan eLab.
Transaction Overview
Company Name
Announced On
6/3/2016
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Arboretum Ventures (Lead Investor) (Jan Garfinkle)
Baird Capital (Lead Investor) (Nicole Walker)
Proceeds Purpose
The financing will fuel Strata's state-of-the-art tumor sequencing operation and implementation of the Strata Trial, a nation-wide effort aimed at substantially increasing the number of enrollments in precision medicine clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8192 Jackson Rd. A
Ann Arbor, MI 48103
USA
Ann Arbor, MI 48103
USA
Phone
Website
Email Address
Not Recorded
Overview
At Strata Oncology, our goal is to dramatically expand late stage cancer patients' access to tumor sequencing and precision medicine trials and to accelerate the approval and availability of breakthrough cancer medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Rhodes
Chief Financial Officer
Matthew Martin
Chief Medical Officer
Scott Tomlins
VP - Bus. Development
Catherine Sazdanoff
VP - Bus. Development
Mark Szewczyk
VP - Engineering
Bryan Johnson
VP - Operations
Kat Kwiatkowski
Browse more venture capital transactions:
Prev: 6/3/2016: Vyze venture capital transaction
Next: 6/3/2016: Docupace Technologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs